tiprankstipranks
Trending News
More News >
InMed Pharmaceuticals (INM)
NASDAQ:INM
US Market

InMed Pharmaceuticals (INM) Technical Analysis

Compare
344 Followers

Technical Sentiment

Overall Consensus
Neutral
11Bullish
2Neutral
9Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
InMed Pharmaceuticals’s (INM) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting InMed Pharmaceuticals is a Sell.
InMed Pharmaceuticals’s (INM) 20-Day exponential moving average is 2.57, while InMed Pharmaceuticals’s (INM) share price is $2.96, making it a Buy.
InMed Pharmaceuticals’s (INM) 50-Day exponential moving average is 2.84, while InMed Pharmaceuticals’s (INM) share price is $2.96, making it a Buy.

InMed Pharmaceuticals (INM) Pivot Points

Apr 22, 2025, 03:30 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.45
2.51
2.61
2.67
2.77
2.83
2.93
Fibonacci
2.51
2.57
2.61
2.67
2.73
2.77
2.83
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

InMed Pharmaceuticals (INM) Moving Averages

Apr 22, 2025, 03:30 PM
Period
Simple
Exponential
MA5
2.75Buy
2.76Buy
MA10
2.58Buy
2.63Buy
MA20
2.45Buy
2.57Buy
MA50
2.73Buy
2.84Buy
MA100
3.58Sell
3.36Sell
MA200
4.30Sell
4.08Sell
InMed Pharmaceuticals’s (INM) 10-Day exponential moving average is 2.63, while InMed Pharmaceuticals’s (INM) share price is $2.96, making it a Buy.
InMed Pharmaceuticals’s (INM) 100-Day exponential moving average is 3.36, while InMed Pharmaceuticals’s (INM) share price is $2.96, making it a Sell.
InMed Pharmaceuticals’s (INM) stock price is $2.96 and InMed Pharmaceuticals’s (INM) 50-day simple moving average is 2.73, creating a Buy signal.
InMed Pharmaceuticals’s (INM) stock price is $2.96 and InMed Pharmaceuticals’s (INM) 100-day simple moving average is 3.58, creating a Sell signal.
InMed Pharmaceuticals’s (INM) stock price is $2.96 and InMed Pharmaceuticals’s (INM) 200-day simple moving average is 4.30, creating a Sell signal.

InMed Pharmaceuticals (INM) Technical Indicators

Apr 22, 2025, 03:30 PM
Name
Value
Implied Action
RSI (14)
60.74
Neutral
STOCH (9,6)
85.35
Sell
STOCHRSI (14)
86.43
Sell
MACD (12,26)
<0.01
Sell
ADX (14)
17.37
Buy
Williams %R
-13.29
Sell
CCI (14)
116.00
Sell
ATR (14)
0.25
-
Ultimate Oscillator
69.76
Neutral
ROC
43.00
Buy
InMed Pharmaceuticals’s (INM) Relative Strength Index (RSI) is 60.74, creating a Neutral signal.
InMed Pharmaceuticals’s (INM) Trend Strength Indicator (ADX) is 17.37, creating a Buy signal.
InMed Pharmaceuticals’s (INM) Commodity Channel Index (CCI) is 116.00, creating a Sell signal.
InMed Pharmaceuticals’s (INM) Price Rate of Change (ROC) is 43.00, creating a Buy signal.

FAQ

Is INM a Buy, Hold, or Sell?
Based on INM’s technical indicators, INM is a Hold.
    What is INM’s RSI (14)?
    INM’s RSI (14) is 60.74, which suggests INM is a Neutral.
      What is INM’s MACD?
      INM’s MACD is <0.01, which suggests INM is a Sell.
        What is INM’s 5-day moving average?
        INM’s 5-day moving average is 2.75, which suggests INM is a Buy.
          What is INM’s 20-day moving average?
          INM 20-day moving average is 2.45, which suggests INM is a Buy.
            What is INM’s 50-day moving average?
            INM’s 50-day moving average is 2.73, which suggests INM is a Buy.
              What is INM’s 200-day moving average?
              INM’s 200-day moving average is 4.30, which suggests INM is a Sell.
                What is INM’s Williams % R (14)?
                INM’s Williams % R (14) is -13.29, which suggests INM is a Sell.
                  What is INM’s CCI (14)?
                  INM’s CCI (14) is 116.00, which suggests INM is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis